REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 209 filers reported holding REATA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.53 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $261,527 | +12.1% | 2,565 | 0.0% | 0.05% | +9.3% |
| Q1 2023 | $233,210 | -9.6% | 2,565 | 0.0% | 0.04% | -8.5% |
| Q3 2021 | $258,000 | -28.9% | 2,565 | 0.0% | 0.05% | -25.4% |
| Q2 2021 | $363,000 | +41.8% | 2,565 | 0.0% | 0.06% | +28.6% |
| Q1 2021 | $256,000 | -46.2% | 2,565 | -33.3% | 0.05% | -52.0% |
| Q4 2020 | $476,000 | +26.9% | 3,848 | 0.0% | 0.10% | +4.1% |
| Q3 2020 | $375,000 | -37.5% | 3,848 | 0.0% | 0.10% | -39.9% |
| Q2 2020 | $600,000 | +8.1% | 3,848 | 0.0% | 0.16% | -15.5% |
| Q1 2020 | $555,000 | -47.1% | 3,848 | -25.0% | 0.19% | -37.9% |
| Q4 2019 | $1,049,000 | – | 5,131 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Conrad N. Hilton Foundation | 63,481 | $7,847,000 | 100.00% |
| CPMG Inc | 2,896,901 | $358,115,000 | 55.16% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 140,000 | $17,307,000 | 26.62% |
| Corriente Advisors, LLC | 525,000 | $64,901,000 | 15.45% |
| DUMAC, INC. | 76,050 | $9,401,000 | 7.33% |
| MADDEN SECURITIES Corp | 35,152 | $4,345,000 | 2.80% |
| Biondo Investment Advisors, LLC | 113,692 | $14,055,000 | 2.69% |
| Duquesne Family Office | 749,897 | $92,702,000 | 2.50% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $3,754,000 | 2.44% |
| Integral Health Asset Management, LLC | 50,000 | $6,181,000 | 1.84% |